Asia-Pacific Journal of Clinical Oncology is an essential publication within the field of medical oncology, dedicated to advancing the understanding and treatment of cancer through rigorous research and innovative clinical practices. Published by WILEY, this journal has established itself as a significant resource for researchers, healthcare professionals, and students interested in the latest findings across the Asia-Pacific region and beyond. With a respectable impact factor and categorized within the Q2 and Q3 quartiles of Medicine (miscellaneous) and Oncology respectively, the journal aims to disseminate knowledge on diverse aspects of clinical oncology, promoting the improvement of patient care and treatment outcomes. The Asia-Pacific Journal of Clinical Oncology, operating from the United Kingdom, invites contributions that highlight significant findings and advancements in oncology, making it a crucial platform for collaboration and knowledge sharing in this vital field of medicine.

Journal of the Egyptian National Cancer Institute, published by SPRINGER, serves as a vital platform for disseminating innovative research in the field of oncology and cancer research. With both ISSN 1110-0362 and E-ISSN 2589-0409, this Open Access journal has been committed to making significant contributions to the scientific community since its inception in 2005. Operating from its base in Egypt, it has established itself as an important resource for researchers, practitioners, and students alike, offering insights into contemporary issues and advancements in cancer care. Recognized in the 2023 category quartiles as Q3 in Cancer Research and Q3 in Oncology, the journal is positioned to impact the ongoing discourse in cancer treatment strategies and health policy. As it continues to publish peer-reviewed articles through available Open Access avenues, the Journal of the Egyptian National Cancer Institute remains dedicated to enhancing the knowledge base and collaborative efforts within the global cancer research community.

Frontiers in Digital Health is an innovative peer-reviewed journal published by FRONTIERS MEDIA SA, focusing on the intersection of digital technology and healthcare. As an Open Access journal since 2020, it aims to democratize knowledge by making cutting-edge research freely available to the global community. The journal covers a wide array of topics within the realms of Biomedical Engineering, Health Informatics, and a variety of Computer Science Applications, ensuring interdisciplinary collaboration and advancements. Recognized for its excellence, it holds prestigious rankings in multiple categories, including Q1 in Biomedical Engineering and Q2 in several related fields according to the 2023 metrics. Set in the heart of Switzerland, the journal fosters a comprehensive approach to enhancing digital health technologies, making it an essential resource for researchers, professionals, and students dedicated to improving health outcomes through innovation.

Healthcare Informatics Research, published by the Korean Society of Medical Informatics, is a leading open access journal that has been advancing the field of healthcare informatics since its inception in 2010. With an ISSN of 2093-3681 and E-ISSN of 2093-369X, the journal provides a vital platform for disseminating high-quality research aimed at improving healthcare systems through innovative informatics solutions. Recognized for its contributions, it holds a Q2 rank in Biomedical Engineering and Q3 rankings in both Health Informatics and Health Information Management for 2023, reflecting its stature within the academic community. The journal is committed to open access, ensuring that research is freely accessible to researchers, professionals, and students worldwide, thus promoting knowledge sharing and collaboration. Located in the dynamic city of Seoul, South Korea, the journal serves as a hub for groundbreaking studies that impact health systems globally, making it an essential resource for those at the forefront of healthcare technology and management.

The Lancet Oncology is a premier peer-reviewed journal published by Elsevier Science Inc., recognized as a leading authority in the field of oncology. With an ISSN of 1470-2045 and E-ISSN 1474-5488, this esteemed journal boasts an impressive 2023 impact factor placing it in the Q1 category of oncology—reflecting its role as a critical resource for cutting-edge research. The journal publishes high-quality articles covering novel scientific discoveries, clinical advancements, and public health issues related to cancer treatment and prevention. It is ranked #5 out of 404 in the Scopus Medicine _ Oncology category, demonstrating its influence and relevance in the field, with an outstanding rank in the 98th percentile. Operating from its base in the United Kingdom, The Lancet Oncology spans a comprehensive timeframe from 2000 to 2024, making it a vital repository of oncology literature. Although it does not primarily operate on an open-access model, its significant subscription base ensures that a wealth of knowledge is accessible to researchers, professionals, and students alike, fostering a profound understanding and advancement in oncology.

JAMIA Open is an open-access journal dedicated to advancing the field of health informatics, published by Oxford University Press. Since its inception in 2018, the journal has provided a platform for novel research, reviews, and case studies that bridge the gap between healthcare and information technology. With an impressive impact factor and a current classification in the Q2 quartile for Health Informatics, JAMIA Open has established itself as a vital resource for researchers and practitioners alike, facilitating the dissemination of innovative findings that contribute to the evolution of healthcare systems. Based in the United States, the journal is committed to providing free and equitable access to high-quality research, thus promoting a collaborative and informed approach to tackling pressing health issues. As it continues to grow and evolve, JAMIA Open remains a cornerstone in the landscape of health informatics, appealing to a diverse audience of researchers, professionals, and students looking to inspire change in their fields.

Welcome to JCO Clinical Cancer Informatics, an esteemed journal at the forefront of the intersection between oncology and health informatics. Published by Lippincott Williams & Wilkins, this journal is dedicated to advancing the understanding and application of cancer data through innovative informatics solutions. Since its inception in 2017, JCO Clinical Cancer Informatics has established itself as a critical resource for researchers, practitioners, and students, as evidenced by its high rankings in the 2023 Scimago Quartiles—Q2 in Cancer Research and Q1 in both Health Informatics and Oncology. With a commitment to open access, this journal aims to disseminate groundbreaking research findings that enhance cancer care and inform public health strategies. Positioned in the United States, it serves as a pivotal platform for sharing knowledge and fostering collaboration within the global cancer research community.

Oncology Reports is a distinguished journal dedicated to advancing knowledge in the field of oncology. Published by Spandidos Publications Ltd, this journal has been a cornerstone in cancer research since its establishment in 1994 and is set to continue its impactful contributions until 2024. With ISSN 1021-335X and E-ISSN 1791-2431, it ranks in the Q2 category in Cancer Research, Medicine (Miscellaneous), and Oncology as of 2023, reflecting its solid standing in the academic community. The journal's current Scopus rankings position it notably within Medicine (Oncology) (#74/404, 81st percentile) and Biochemistry, Genetics and Molecular Biology (Cancer Research) (#67/230, 71st percentile), underscoring its rigorous peer-review process and the quality of its published research. Although not an open-access journal, Oncology Reports remains committed to disseminating vital information to researchers, professionals, and students, ensuring they stay at the forefront of developments in cancer studies. Its comprehensive scope promotes a multidisciplinary approach, encompassing clinical and experimental aspects of oncology, thus serving as an essential resource for those striving to understand and combat cancer.

The JOURNAL OF CANCER EDUCATION, published by SPRINGER, stands as a pivotal resource in the fields of oncology and public health. With an ISSN of 0885-8195 and an E-ISSN of 1543-0154, this esteemed journal has been disseminating vital research since 1986 and continues to play a crucial role in advancing knowledge until 2024. Recognized in 2023 with a Q3 rating in Oncology and a Q2 rating in Public Health, it reflects a solid standing in an ever-evolving academic landscape. The journal ranks #297 out of 665 in the Public Health category and #233 out of 404 in Oncology, showcasing its contribution to the scientific community. Aimed at researchers, practitioners, and students alike, the journal invites submissions that enhance understanding of cancer education, prevention, and management, ensuring that the knowledge shared is both impactful and accessible. With its focus on evidence-based practices and innovative educational strategies in cancer care, the JOURNAL OF CANCER EDUCATION serves as an essential platform for fostering collaboration and progress in oncology education.

PSYCHO-ONCOLOGY is a leading international journal published by Wiley, focusing on the interdisciplinary fields of psychology and oncology. Established in 1992 and continuing its impactful contributions to academic discourse through 2024, the journal occupies a prestigious position with a Q1 ranking in Experimental and Cognitive Psychology and notable placements in both Oncology and Psychiatry and Mental Health categories. With an impressive Scopus ranking that places it in the 86th and 76th percentiles within its respective fields, PSYCHO-ONCOLOGY facilitates the exploration of psychological dimensions of cancer and its treatment, emphasizing evidence-based research that greatly informs clinical practices. Researchers, professionals, and students benefit from its comprehensive scope, which encompasses mental health implications linked to cancer diagnosis, treatment, and survivorship. Although it operates on a subscription model, the journal remains a vital resource for advancing knowledge and promoting psychosocial well-being in oncology, making it an essential read for those dedicated to improving patient outcomes.